Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 127 entries
Sorted by: Best Match Show Resources per page
The stopped-drop method: a novel setup for containment-free and time-resolved measurements.

Journal of synchrotron radiation

Schiener A, Seifert S, Magerl A.
PMID: 26917142
J Synchrotron Radiat. 2016 Mar;23(2):545-50. doi: 10.1107/S1600577515023826. Epub 2016 Feb 02.

A novel setup for containment-free time-resolved experiments at a free-hanging drop is reported. Within a dead-time of 100 ms a drop of mixed reactant solutions is formed and the time evolution of a reaction can be followed from thereon...

Cite
Schiener A, Seifert S, Magerl A. The stopped-drop method: a novel setup for containment-free and time-resolved measurements. J Synchrotron Radiat. 2016;23(2):545-50doi: 10.1107/S1600577515023826.
Schiener, A., Seifert, S., & Magerl, A. (2016). The stopped-drop method: a novel setup for containment-free and time-resolved measurements. Journal of synchrotron radiation, 23(2), 545-50. https://doi.org/10.1107/S1600577515023826
Schiener, Andreas, et al. "The stopped-drop method: a novel setup for containment-free and time-resolved measurements." Journal of synchrotron radiation vol. 23,2 (2016): 545-50. doi: https://doi.org/10.1107/S1600577515023826
Schiener A, Seifert S, Magerl A. The stopped-drop method: a novel setup for containment-free and time-resolved measurements. J Synchrotron Radiat. 2016 Mar;23(2):545-50. doi: 10.1107/S1600577515023826. Epub 2016 Feb 02. PMID: 26917142.
Copy Download .nbib Format: NLM
Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015.

Journal of clinical medicine

Chang MH, Moonesinghe R, Schieber LZ, Truman BI.
PMID: 31652928
J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111768.

Unsterile opioid injection increases risk for infection transmission, including HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV). We assess prevalence of and risk factors associated with opioid overdose and infections with HIV, HBV, or HCV among Medicare...

Cite
Chang MH, Moonesinghe R, Schieber LZ, et al. Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015. J Clin Med. 2019;8(11)doi: 10.3390/jcm8111768.
Chang, M. H., Moonesinghe, R., Schieber, L. Z., & Truman, B. I. (2019). Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015. Journal of clinical medicine, 8(11), . https://doi.org/10.3390/jcm8111768
Chang, Man-Huei, et al. "Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015." Journal of clinical medicine vol. 8,11 (2019). doi: https://doi.org/10.3390/jcm8111768
Chang MH, Moonesinghe R, Schieber LZ, Truman BI. Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015. J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111768. PMID: 31652928; PMCID: PMC6912616.
Copy Download .nbib Format: NLM
Chemical Glucosylation of Labile Natural Products Using a (2-Nitrophenyl)acetyl-Protected Glucosyl Acetimidate Donor.

European journal of organic chemistry

Weber J, Schwarz M, Schiefer A, Hametner C, Häubl G, Fröhlich J, Mikula H.
PMID: 29937688
European J Org Chem. 2018 Jun 07;2018(20):2701-2706. doi: 10.1002/ejoc.201800260. Epub 2018 Apr 26.

The synthesis of (2-nitrophenyl)acetyl (NPAc)-protected glucosyl donors is described that were designed for the neighboring-group assisted glucosylation of base-labile natural products also being sensitive to hydrogenolysis. Glycosylation conditions were optimized using a trichloroacetimidate glucosyl donor, and cyclohexylmethanol and (+)-menthol...

Cite
Weber J, Schwarz M, Schiefer A, et al. Chemical Glucosylation of Labile Natural Products Using a (2-Nitrophenyl)acetyl-Protected Glucosyl Acetimidate Donor. European J Org Chem. 2018;2018(20):2701-2706doi: 10.1002/ejoc.201800260.
Weber, J., Schwarz, M., Schiefer, A., Hametner, C., Häubl, G., Fröhlich, J., & Mikula, H. (2018). Chemical Glucosylation of Labile Natural Products Using a (2-Nitrophenyl)acetyl-Protected Glucosyl Acetimidate Donor. European journal of organic chemistry, 2018(20), 2701-2706. https://doi.org/10.1002/ejoc.201800260
Weber, Julia, et al. "Chemical Glucosylation of Labile Natural Products Using a (2-Nitrophenyl)acetyl-Protected Glucosyl Acetimidate Donor." European journal of organic chemistry vol. 2018,20 (2018): 2701-2706. doi: https://doi.org/10.1002/ejoc.201800260
Weber J, Schwarz M, Schiefer A, Hametner C, Häubl G, Fröhlich J, Mikula H. Chemical Glucosylation of Labile Natural Products Using a (2-Nitrophenyl)acetyl-Protected Glucosyl Acetimidate Donor. European J Org Chem. 2018 Jun 07;2018(20):2701-2706. doi: 10.1002/ejoc.201800260. Epub 2018 Apr 26. PMID: 29937688; PMCID: PMC6001546.
Copy Download .nbib Format: NLM
Anomalies of pressure broadening in the H2 S0(3) transition versus perturber concentration.

Physical review. A, Atomic, molecular, and optical physics

Anselm N, Bonamy J, Robert D, Schieder R, Winnewisser G.
PMID: 9913246
Phys Rev A. 1996 May;53(5):3087-3091. doi: 10.1103/physreva.53.3087.

No abstract available.

Cite
Anselm N, Bonamy J, Robert D, et al. Anomalies of pressure broadening in the H2 S0(3) transition versus perturber concentration. Phys Rev A. 1996;53(5):3087-3091doi: 10.1103/physreva.53.3087.
Anselm, N., Bonamy, J., Robert, D., Schieder, R., & Winnewisser, G. (1996). Anomalies of pressure broadening in the H2 S0(3) transition versus perturber concentration. Physical review. A, Atomic, molecular, and optical physics, 53(5), 3087-3091. https://doi.org/10.1103/physreva.53.3087
Anselm, et al. "Anomalies of pressure broadening in the H2 S0(3) transition versus perturber concentration." Physical review. A, Atomic, molecular, and optical physics vol. 53,5 (1996): 3087-3091. doi: https://doi.org/10.1103/physreva.53.3087
Anselm N, Bonamy J, Robert D, Schieder R, Winnewisser G. Anomalies of pressure broadening in the H2 S0(3) transition versus perturber concentration. Phys Rev A. 1996 May;53(5):3087-3091. doi: 10.1103/physreva.53.3087. PMID: 9913246.
Copy Download .nbib Format: NLM
Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients.

Pediatric transplantation

Hind T, Lui S, Moon E, Broad K, Lang S, Schreiber RA, Armstrong K, Blydt-Hansen TD.
PMID: 33769652
Pediatr Transplant. 2021 Jun;25(4):e14005. doi: 10.1111/petr.14005. Epub 2021 Mar 26.

Living with end-stage organ failure is associated with an accumulation of traumatic medical events, and despite recovery after solid-organ transplantation (SOT), many children continue to exhibit lower quality of life (QOL). Few studies have examined the relationship between post-traumatic...

Cite
Hind T, Lui S, Moon E, et al. Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients. Pediatr Transplant. 2021;25(4):e14005doi: 10.1111/petr.14005.
Hind, T., Lui, S., Moon, E., Broad, K., Lang, S., Schreiber, R. A., Armstrong, K., & Blydt-Hansen, T. D. (2021). Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients. Pediatric transplantation, 25(4), e14005. https://doi.org/10.1111/petr.14005
Hind, Tatsuma, et al. "Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients." Pediatric transplantation vol. 25,4 (2021): e14005. doi: https://doi.org/10.1111/petr.14005
Hind T, Lui S, Moon E, Broad K, Lang S, Schreiber RA, Armstrong K, Blydt-Hansen TD. Post-traumatic stress as a determinant of quality of life in pediatric solid-organ transplant recipients. Pediatr Transplant. 2021 Jun;25(4):e14005. doi: 10.1111/petr.14005. Epub 2021 Mar 26. PMID: 33769652.
Copy Download .nbib Format: NLM
Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome.

Neurocritical care

Chen M, Kronsteiner D, Pfaff J, Schieber S, Jäger L, Bendszus M, Kieser M, Möhlenbruch MA, Ringleb PA, Bösel J, Schönenberger S.
PMID: 34142339
Neurocrit Care. 2021 Jun 17; doi: 10.1007/s12028-021-01229-w. Epub 2021 Jun 17.

BACKGROUND: Optimal blood pressure (BP) management during endovascular stroke treatment in patients with large-vessel occlusion is not well established. We aimed to investigate associations of BP during different phases of endovascular therapy with reperfusion and functional outcome.METHODS: We performed...

Cite
Chen M, Kronsteiner D, Pfaff J, et al. Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome. Neurocrit Care. 2021;doi: 10.1007/s12028-021-01229-w.
Chen, M., Kronsteiner, D., Pfaff, J., Schieber, S., Jäger, L., Bendszus, M., Kieser, M., Möhlenbruch, M. A., Ringleb, P. A., Bösel, J., & Schönenberger, S. (2021). Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome. Neurocritical care, . https://doi.org/10.1007/s12028-021-01229-w
Chen, Min, et al. "Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome." Neurocritical care vol. (2021). doi: https://doi.org/10.1007/s12028-021-01229-w
Chen M, Kronsteiner D, Pfaff J, Schieber S, Jäger L, Bendszus M, Kieser M, Möhlenbruch MA, Ringleb PA, Bösel J, Schönenberger S. Hemodynamic Status During Endovascular Stroke Treatment: Association of Blood Pressure with Functional Outcome. Neurocrit Care. 2021 Jun 17; doi: 10.1007/s12028-021-01229-w. Epub 2021 Jun 17. PMID: 34142339.
Copy Download .nbib Format: NLM
The Impact of a Novel Operational Readiness Response Model on the Environmental Cleanliness of Emergency Ambulances.

Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors

Morris D, Fierravanti G, Schrieber A, Johnson S, Bartolo D, Hipsley K, Somani T, Pap R, Agho K, Thyer L, Simpson PM.
PMID: 33528288
Prehosp Emerg Care. 2021 Feb 26;1-13. doi: 10.1080/10903127.2021.1884323. Epub 2021 Feb 26.

No abstract available.

Cite
Morris D, Fierravanti G, Schrieber A, et al. The Impact of a Novel Operational Readiness Response Model on the Environmental Cleanliness of Emergency Ambulances. Prehosp Emerg Care. 2021;1-13doi: 10.1080/10903127.2021.1884323.
Morris, D., Fierravanti, G., Schrieber, A., Johnson, S., Bartolo, D., Hipsley, K., Somani, T., Pap, R., Agho, K., Thyer, L., & Simpson, P. M. (2021). The Impact of a Novel Operational Readiness Response Model on the Environmental Cleanliness of Emergency Ambulances. Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors, 1-13. https://doi.org/10.1080/10903127.2021.1884323
Morris, David, et al. "The Impact of a Novel Operational Readiness Response Model on the Environmental Cleanliness of Emergency Ambulances." Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors vol. (2021): 1-13. doi: https://doi.org/10.1080/10903127.2021.1884323
Morris D, Fierravanti G, Schrieber A, Johnson S, Bartolo D, Hipsley K, Somani T, Pap R, Agho K, Thyer L, Simpson PM. The Impact of a Novel Operational Readiness Response Model on the Environmental Cleanliness of Emergency Ambulances. Prehosp Emerg Care. 2021 Feb 26;1-13. doi: 10.1080/10903127.2021.1884323. Epub 2021 Feb 26. PMID: 33528288.
Copy Download .nbib Format: NLM
LKB1/.

Cancer discovery

Marinaccio C, Suraneni P, Celik H, Volk A, Wen QJ, Ling T, Bulic M, Lasho T, Koche RP, Famulare CA, Farnoud N, Stein B, Schieber M, Gurbuxani S, Root DE, Younger ST, Hoffman R, Gangat N, Ntziachristos P, Chandel NS, Levine RL, Rampal RK, Challen GA, Tefferi A, Crispino JD.
PMID: 33579786
Cancer Discov. 2021 Jun;11(6):1398-1410. doi: 10.1158/2159-8290.CD-20-1353. Epub 2021 Feb 12.

The myeloproliferative neoplasms (MPN) frequently progress to blast phase disease, an aggressive form of acute myeloid leukemia. To identify genes that suppress disease progression, we performed a focused CRISPR/Cas9 screen and discovered that depletion of LKB1/

Cite
Marinaccio C, Suraneni P, Celik H, et al. LKB1/. Cancer Discov. 2021;11(6):1398-1410doi: 10.1158/2159-8290.CD-20-1353.
Marinaccio, C., Suraneni, P., Celik, H., Volk, A., Wen, Q. J., Ling, T., Bulic, M., Lasho, T., Koche, R. P., Famulare, C. A., Farnoud, N., Stein, B., Schieber, M., Gurbuxani, S., Root, D. E., Younger, S. T., Hoffman, R., Gangat, N., Ntziachristos, P., Chandel, N. S., Levine, R. L., Rampal, R. K., Challen, G. A., Tefferi, A., & Crispino, J. D. (2021). LKB1/. Cancer discovery, 11(6), 1398-1410. https://doi.org/10.1158/2159-8290.CD-20-1353
Marinaccio, Christian, et al. "LKB1/." Cancer discovery vol. 11,6 (2021): 1398-1410. doi: https://doi.org/10.1158/2159-8290.CD-20-1353
Marinaccio C, Suraneni P, Celik H, Volk A, Wen QJ, Ling T, Bulic M, Lasho T, Koche RP, Famulare CA, Farnoud N, Stein B, Schieber M, Gurbuxani S, Root DE, Younger ST, Hoffman R, Gangat N, Ntziachristos P, Chandel NS, Levine RL, Rampal RK, Challen GA, Tefferi A, Crispino JD. LKB1/. Cancer Discov. 2021 Jun;11(6):1398-1410. doi: 10.1158/2159-8290.CD-20-1353. Epub 2021 Feb 12. PMID: 33579786; PMCID: PMC8178182.
Copy Download .nbib Format: NLM
Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France.

Infectious diseases now

Martinot M, Eyriey M, Gravier S, Kayser D, Ion C, Mohseni-Zadeh M, Ongagna JC, Schieber A, Kempf C.
PMID: 34634485
Infect Dis Now. 2021 Oct 08; doi: 10.1016/j.idnow.2021.10.002. Epub 2021 Oct 08.

OBJECTIVES: Two COVID-19 epidemic waves occurred in France in 2020. This single-center retrospective study compared patients' characteristics and outcomes.PATIENTS AND METHODS: We included all patients with confirmed COVID-19 admitted to Colmar Hospital in March (n=600) and October/November (n=205) 2020.RESULTS:...

Cite
Martinot M, Eyriey M, Gravier S, et al. Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France. Infect Dis Now. 2021;doi: 10.1016/j.idnow.2021.10.002.
Martinot, M., Eyriey, M., Gravier, S., Kayser, D., Ion, C., Mohseni-Zadeh, M., Ongagna, J. C., Schieber, A., Kempf, C. (2021). Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France. Infectious diseases now, . https://doi.org/10.1016/j.idnow.2021.10.002
Martinot, M, et al. "Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France." Infectious diseases now vol. (2021). doi: https://doi.org/10.1016/j.idnow.2021.10.002
Martinot M, Eyriey M, Gravier S, Kayser D, Ion C, Mohseni-Zadeh M, Ongagna JC, Schieber A, Kempf C. Evolution of baseline characteristics and severe outcomes in COVID-19 inpatients during the first and second waves in Northeastern France. Infect Dis Now. 2021 Oct 08; doi: 10.1016/j.idnow.2021.10.002. Epub 2021 Oct 08. PMID: 34634485; PMCID: PMC8500690.
Copy Download .nbib Format: NLM
Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Schieber TJ, Bennett N, Aragon L, Ploetz J, Boyd S.
PMID: 34107027
Am J Health Syst Pharm. 2021 Jun 09; doi: 10.1093/ajhp/zxab245. Epub 2021 Jun 09.

In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical...

Cite
Schieber TJ, Bennett N, Aragon L, et al. Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min. Am J Health Syst Pharm. 2021;doi: 10.1093/ajhp/zxab245.
Schieber, T. J., Bennett, N., Aragon, L., Ploetz, J., & Boyd, S. (2021). Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, . https://doi.org/10.1093/ajhp/zxab245
Schieber, Timothy J, et al. "Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. (2021). doi: https://doi.org/10.1093/ajhp/zxab245
Schieber TJ, Bennett N, Aragon L, Ploetz J, Boyd S. Real-world risk evaluation of remdesivir in patients with an estimated glomerular filtration rate of less than 30 mL/min. Am J Health Syst Pharm. 2021 Jun 09; doi: 10.1093/ajhp/zxab245. Epub 2021 Jun 09. PMID: 34107027; PMCID: PMC8344606.
Copy Download .nbib Format: NLM
Ferroelasticity, anelasticity and magnetoelastic relaxation in Co-doped iron pnictide: Ba(Fe.

Journal of physics. Condensed matter : an Institute of Physics journal

Carpenter MA, Evans DM, Schiemer JA, Wolf T, Adelmann P, Böhmer AE, Meingast C, Dutton SE, Mukherjee P, Howard CJ.
PMID: 30641499
J Phys Condens Matter. 2019 Apr 17;31(15):155401. doi: 10.1088/1361-648X/aafe29. Epub 2019 Jan 14.

The hypothesis that strain has a permeating influence on ferroelastic, magnetic and superconducting transitions in 122 iron pnictides has been tested by investigating variations of the elastic and anelastic properties of a single crystal of Ba(Fe

Cite
Carpenter MA, Evans DM, Schiemer JA, et al. Ferroelasticity, anelasticity and magnetoelastic relaxation in Co-doped iron pnictide: Ba(Fe. J Phys Condens Matter. 2019;31(15):155401doi: 10.1088/1361-648X/aafe29.
Carpenter, M. A., Evans, D. M., Schiemer, J. A., Wolf, T., Adelmann, P., Böhmer, A. E., Meingast, C., Dutton, S. E., Mukherjee, P., & Howard, C. J. (2019). Ferroelasticity, anelasticity and magnetoelastic relaxation in Co-doped iron pnictide: Ba(Fe. Journal of physics. Condensed matter : an Institute of Physics journal, 31(15), 155401. https://doi.org/10.1088/1361-648X/aafe29
Carpenter, M A, et al. "Ferroelasticity, anelasticity and magnetoelastic relaxation in Co-doped iron pnictide: Ba(Fe." Journal of physics. Condensed matter : an Institute of Physics journal vol. 31,15 (2019): 155401. doi: https://doi.org/10.1088/1361-648X/aafe29
Carpenter MA, Evans DM, Schiemer JA, Wolf T, Adelmann P, Böhmer AE, Meingast C, Dutton SE, Mukherjee P, Howard CJ. Ferroelasticity, anelasticity and magnetoelastic relaxation in Co-doped iron pnictide: Ba(Fe. J Phys Condens Matter. 2019 Apr 17;31(15):155401. doi: 10.1088/1361-648X/aafe29. Epub 2019 Jan 14. PMID: 30641499.
Copy Download .nbib Format: NLM
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A.

Pharmaceutics

Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R, Chaverra-Muñoz L, Hübner MP, Pfarr K, Hesterkamp T, Stadler M, Gütschow M, König GM, Hoerauf A, Wagner KG.
PMID: 33217948
Pharmaceutics. 2020 Nov 18;12(11). doi: 10.3390/pharmaceutics12111105.

Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was...

Cite
Krome AK, Becker T, Kehraus S, et al. Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics. 2020;12(11)doi: 10.3390/pharmaceutics12111105.
Krome, A. K., Becker, T., Kehraus, S., Schiefer, A., Steinebach, C., Aden, T., Frohberger, S. J., López Mármol, �. �., Kapote, D., Jansen, R., Chaverra-Muñoz, L., Hübner, M. P., Pfarr, K., Hesterkamp, T., Stadler, M., Gütschow, M., König, G. M., Hoerauf, A., & Wagner, K. G. (2020). Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics, 12(11), . https://doi.org/10.3390/pharmaceutics12111105
Krome, Anna K, et al. "Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A." Pharmaceutics vol. 12,11 (2020). doi: https://doi.org/10.3390/pharmaceutics12111105
Krome AK, Becker T, Kehraus S, Schiefer A, Steinebach C, Aden T, Frohberger SJ, López Mármol Á, Kapote D, Jansen R, Chaverra-Muñoz L, Hübner MP, Pfarr K, Hesterkamp T, Stadler M, Gütschow M, König GM, Hoerauf A, Wagner KG. Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A. Pharmaceutics. 2020 Nov 18;12(11). doi: 10.3390/pharmaceutics12111105. PMID: 33217948; PMCID: PMC7698778.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 127 entries